Bratton Capital Management, L.P.
Follow13F filer, CIK 1723787, FORT WORTH, TX
Bratton Capital Management, L.P. reported $40,715,476 across 1 holding for the quarter ended 2026-03-31, in a 13F-HR filed 2026-05-13.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001315863-26-000406
- Period
- 2026-03-31
- Reported value
- $40.7M
- Holdings
- 1
- Top 10 weight
- 100%
- New
- 0
- Sold out
- 0
Part of the filer group Bratton Capital Management, L.P.
Bratton Capital Inc.Bratton Family Partners L.P.
- Bratton Capital Inc.
- Bratton Family Partners L.P.
- MonoLine Partners, L.P.
- MonoLine RX III, L.P.
- MonoLine RX II, L.P.
- MonoLine RX, L.P.
- MonoSol Rx Genpar, L.P.
- BRATTON DOUGLAS K
Holdings, Q1 2026
Share positions as resolved from 13F-HR 0001315863-26-000406, largest first. % of portfolio is the value over $40,715,476, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| AQSTAQUESTIVE THERAPEUTICS INC | 9,810,958 | $40.7M | 100% | 0 | 2026-10-07, 13G/A: 691,873 shares, 0.6% of the class, 13G/A filed 2026-10-07 | Timeline |
How Q1 2026 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001315863-26-000406 | base | 2026-05-13 | acceptance time not in the bulk data set |